Olaratumab Approved to Treat Advanced Soft Tissue Sarcoma



The Food and Drug Administration (FDA) has granted accelerated approval to olaratumab (Lartruvo®) for the treatment of some patients with soft tissue sarcoma.



Source link

Comments are closed.